Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
330
NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
Phase: Phase 2/3
Role: Lead Sponsor
Start: Apr 23, 2020
Completion: Jul 31, 2020